Skip to main content

Part of UT Health San Antonio

Profiles - UT Health San AntonioProfiles - UT Health Science Center San Antonio

Part of UT Health San Antonio

Menu
  • Home

You are here

  • Profiles Home
  • Faculty Directory
  • Mitzi Gonzales, PhD, ABPP-CN
Mitzi Gonzales, PhD, ABPP-CN

Contact

For administrative calls, please contact:

  • gonzalesm20@uthscsa.edu

Departments & Divisions

  • Department of Neurology

Institutes & Centers

  • Biggs Institute

Research

Research profile

Clinical

Provider profile

Mitzi Gonzales, PhD, ABPP-CN

Assistant Professor/Clinical

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases

  • Professional Background

    Education

    • 2015 - PhD - Clinical Psychology - University of Texas at Austin
    • 2011 - MA - clinical Psychoogy - University of Texas at Austin
    • 2006 - BA - Psychology - Occidental College, Los Angeles, CA

    Training

    • 2017 - Fellowship - clinical Neuropsychology - VA Northern California
    • 2015 - Internship - Clinical Psychology - University of Chicago at Illinois

    Highlights

    06/2022   Article of the Year.   Revisiting apathy in Alzheimer’s disease: From conceptualization to therapeutic approaches). Behavioral Neurology  
    09/2020   Selected Fellow of the Inaugural Class. Institute on Methods & Protocols for Advancement of Clinical Trials in Alzheimer’s Disease 
    06/2020   Best Research Abstract. International Society to Advance, Alzheimer’s Research and Treatment
    05/2020   Selected Scholar of the Univ of Michigan Pepper Ctr Mock Study Retreat
     

    Appointments

    • 10/2022 - Associate Professor with Tenure - UT Health San Antonio, Dept of Radiology, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases
    • 09/2022 - Associate Professor with Tenure - UT Health San Antonio, Dept of Neurology, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases
    • 08/2021-08/2022 - Assistant Professor - UT Health San Antonio, Dept of Neurology, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases
    • 10/2017-06/2021 - Assistant Professor/Clinical - UT Health San Antonio, Dept of Neurology, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases
  • Instruction & Training

    • 12/20/2022, Neuropsychological Outcomes Following organ Transplantation, Dell Medical School, UT Austin Neuropsychology Didactics
    • 07/20/22, Levy Body Dementia, Dell Medical School, UT Austin Neuropsychology Didactics
    • 05/12/21, Parkonson's Dementia & Lewy body Dementia, UTHSCSA School of Medicine Neurology Residency Program
    • 03/19/21, Senescene as a Mechanism Underlying Alzheimer's Disease, UTHSCSA School of Medicine, Neurology Grand Rounds
    • 01/20/21, Neuropsychological Outcomes Following Organ Transplantation, Dell Medical School, UT Austin Neuropsychology Didactics
    • 04/10/2020, Sleep Disturbances - Harbingers and Promoters of Neurodegenerative Disease, UTHSCSA School of Medicine, Neurology Grand Rounds
    • 03/13/20, Sleep Disturbances and Dementia, Audie Murphy VA Neuropsychology Grand Rounds
    • 05/11/19, Parkinson's Dementia & Lewy body Dementia, UTHSCSA School of Medicine Neurology Resident Program
    • 03/15/19, Big Data and Public Health - Issues in Dementia Research, UTHSCSA School of Medicine, Joint MD/MPH Program
    • 02/15/19, Professional and Ethical Issues in Clinical Neuropsychology , Audie Murphy VA Neuropsychology Grand Rounds
    • 10/22/18, Dementia Updates - American Academy of Neurology and American Psychiatric Association, UTHSCSA School of Medicine, Neurology Grand Rounds
  • Research & Grants

    Research profile

    Grants

    • The RSELVES Study: Remote Sensing of Engagement in Life and Variability in Everyday Support Characterizing Older Mexican (American) Participation in Activity Digitally Reliably and Ecologically with the CART Platform (COMPADRE CART): Implications for Cognition & ADRD Multiethnic Machine Learning Signatures of ADRD
    • Epidemiology of Blood Pressure Responses to Perturbations: Correlates & Prognosis for vascular risk, end-organ damage, cognitive aging, and preclinical Alzheimer’s disease
    • Identifying ADRD intervention targets by characterizing neurobiological mechanisms of social isolation, loneliness, and social environment using novel imaging, molecular markers, and machine learning
  • Service

    Department

    09/29/2021                 UTHSCSA Pepper Center    (External Advisory Board Meeting)
    05/24/2021                 South Texas Alzheimer’s Center    (External Advisory Board Meeting)
    01/2021 – Present      National Alzheimer’s Coordinating    (Neuropsychology Lead Center Dementia Consensus Reviews)
    06/2020 – Present      Neuropsychology Fellowship Progam
    05/2020 – Present      Biggs Research Assistant Cognitive Assessment Training 
    10/2019 – Present      Neuropsychology Research
     

    Institutional

    03/15/2020                  UTHSCSA Pepper Center Council  (Advisory Board)
    06/2020 – Present       South Texas Alzheimer’s Center Clinical Core  (Co-Leader)
    10/2018 –  10/2020     UTHSCSA School of Nursing Caring for the Caregiver Program. (Instructor)               

                                                               

    Service to the Profession

    02/10/2023   Health Education           Developments Alzheimer’s And Related Dementias. (Presenter)
    10/19/2022   Health Education           Preclinical Indicators of Disease  (Presenter)
    10/03/2022   Health Education           Developments in Treatment And Prevention of Alzheimer’s. (Presenter)
    09/23/2022   Health Education           Dementia and Sleep  (Presenter)
    03/16/2021   Health Education           Participation in Health Science Research (Educator)

    National

    01/2023-Present     National Alzheimer’s Coordinating Center Scientific Review Committee 
    01/2023-Present     DISCOVERY Study Cognitive Core Committee 
    06/2022                   Clinical Trials for Alzheimer’s Disease  (Abstract Reviewer)
    05/2022                   American Aging Association  (Abstract Reviewer)
    01/2021 – Present   American Federation for Aging Research National Scientific Advisory Council
    06/2018 – Present   MarkVCID Clinical Core Committee  (Site Leader)
    01/2018 – 06/2022  Framingham Heart Study Dementia Dementia Case Consensus Committee  (Neuropsychology Lead)

     

     

    Community

    10/2018 & 10/2019        South Texas Alzheimer’s Disease Community Conference. (Biggs Representative)
    10/2018 & 10/2019        Walk to End Alzheimer’s Disease  (Biggs Representative) 

                

  • Publications

      1. Salem, H, Suchting, R, Gonzales, M. M, Seshadri, S, Teixeira, AL. (2023). Apathy as a predictor of conversion from mild cognitive impairment to Alzheimer’s disease: A Texas Alzheimer’s Research and Care Consortium Cohort-based analysis. Journal of Alzheimer’s Disease (online ahead of print). 
      2. Gonzales, M. M, Wiedner, C, Wang, C, Liu, Q, Bis, JC, Li, Z, et al. (2022). A population-based meta-analysis of circulating GFAP for cognition and dementia risk. Annals of Clinical Translational Neurology, 9(10): 1574-1585.
      3. Gonzales, M. M, Garbarino, V. R., Pollet, E., Palavicini, J. P., Kellogg, D. L., Kraig, E., & Orr, M. E. (2022). Biological aging processes underlying cognitive decline and neurodegenerative disease. The Journal of Clinical Investigation, 132, e158453.
      4. Miller, LM, Steele, JS, Wu, CY, Kaye, J, Dodge, HH, Gonzales, M. M, Lyons, KS. (2022). Depressive symptoms in older adult couples: Associations with dyadic physical health, social engagement, and close friends. Frontiers in Psychiatry, 13, 989128.
      5. Gonzales, M.M, Garbarino, VR, Marques Zilli, E, Petersen, RC, Kirkland, JL, Tchkonia, T, Musi, N, Seshadri, S, Craft, S, Orr, ME. (2022). Senolytic therapy to modulate the progression of Alzheimer’s disease (SToMP-AD): A pilot clinical trial. Journal of Prevention of Alzheimer’s Disease, 9, 22-29.
      6. Zheng, Y, Habes, M, Gonzales, M.M, Pomponio, R, Nasrallah, I, Khan, S, et al. (2022). Mid-life epigenetic age, neuroimaging brain age, and cognitive function: coronary artery risk development in young adults (CARDIA) study. Aging, 14(4), 1691-1712.
      7. DeVito, LM, Barzilai, N, Cuervo, AM, Niedernhofer, LJ, Milman, S, Levine M, Proislow, D, Ferruci, L, Kuchel, GA, Mannick, J, Justice, J, AL, Gonzales, M.M, Kirkland, JL, Cohen P, Campisi (2022). Extending human healthspan and longevity: a symposium report. Annals of the New York Academy of Sciences, 1507, 70-83.
      8. Gonzales, M. M., Wang, C. P., Short, M. I., Parent, D. M., Kautz, T., MacCarthy, D et al. (2022). Blood biomarkers for cognitive decline and clinical progression in a Mexican American cohort. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 14(1), e12298.
      9. Quiroz, YT Solis, M, Aranda, MP, Arbaje, AI, Arroyo‐Miranda, M, Cabrera, LY, Carrasquillo, MM, Corrado, MM, Crivell, L, Diminch, ED, Dorsman, KA, Gonzales, MM. et al. (2022). Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium. Alzheimer's & Dementia, 18, 1677-1686.
      10. Lin, H., Himali, J. J., Satizabal, C. L., Beiser, A. S., Levy, D., Benjamin, E. J., Gonzales, M.M, et al. (2022). Identifying Blood biomarkers for dementia using machine learning methods in the Framingham Heart Study. Cells, 11(9), 1506.
      11. McGrath, E. R., Beiser, A. S., O’Donnell, A., Yang, Q., Ghosh, S., Gonzales, M.M., et al. (2022). Blood phosphorylated tau 181 as a biomarker for amyloid burden on brain PET in cognitively healthy adults. Journal of Alzheimer's Disease, doi: 10.3233/JAD-215639. 
      12. Salinas, J, Beiser, AS, Samra, JK, O’Donnell, A, DeCarli, CS, Gonzales, M.M, Aparicio, HJ, Seshadri, S (2022). Association of loneliness with 10-year dementia risk and early markers of vulnerability for neurocognitive decline. Neurology, 98, e1337-e1348.
      13. Baril, AA, Beiser, AS, Sanchez, E, Mysliwiec, V, Redline, S, Gottlieb, DJ, O’Conner, GT, Gonzales, M.M, Jacob, Himali, D, A, Seshadri, S, Himali, JJ, Pase, M (2022). Insomnia symptom severity and cognitive performance: Moderating role of the APOE genotype. Alzheimer’s & Dementia, 18, 408-421.
      14. González, D.A., Clark, MJ, Gonzales, M. M., Benje, J. (2022). A brief report: An evaluation of item bias on the Functional Activities Questionnaire. Archives of Clinical Neuropsychology (Online ahead of present). 
      15. González, D. A., Resch, Z. J., Gonzales, M. M., Soble, J. R. (2022). A novel method for establishing functional change in older adults with cognitive impairment. Alzheimer’s Disease and Associated Disorders, 36, 238-243. 
      16. Gonzalez, D.A., Gonzales, M.M., Resch, Z.J., Sullivan, A.C., Soble, J.R. (2022). Comprehensive evaluation of the Functional Activities Questionnaire (FAQ) and its reliability and validity. Assessment, 29, 748-763. 
      17. Texeira, AL, Salen, H, Martins, LB, Gonzales, M.M, Seshadri, S, Suchting, R (2022). Factors associated with apathy in Alzheimer’s disease: A cross-sectional analysis of the Texas Alzheimer’s Research and Care Consortium. Journal of Alzheimer’s Disease, 86, 403-411.
      18. Gonzales, M.M, Krishnamurthy, S, Garbarino, V, Daeihagh, AS, Gilispie, GJ, Deep G, Craft, S, Orr, ME. (2021). A geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials. Mechanisms of Ageing and Development, 200, 11589.
      19. Texeira, AL, Gonzales, M.M, De Souza, LC, Weisenbach, S. (2021). Revisiting apathy in Alzheimer’s disease: From conceptualization to therapeutic approaches. Behavioral Neurology,3, 6319826.
      20. Gonzales, M.M, Samra, J, O’Donnell, A, Mackin, S.R, Salinas, J, Jacob, M, Satizabal, C.L, Aparicio, H.J, Thibault, E.G, Sanchez, J.S,  Finney, R, Rubinstein, Z.B, Mayblyum, D.V, Kiliany, R.J, DeCarli, C.S, Johnson, K.A, Beiser, A.S, Seshadri, S. (2021). Association of midlife depressive symptoms with regional amyloid beta and tau in the Framingham Heart Study. Journal of Alzheimer’s Disease, 82, 249-260.
      21. Gonzalez, D.A., Resch ZJ, Gonzales, M.M., Soble JR, Fonggang (2021). Cognitive screening with functional assessment improves diagnostic accuracy and attenuates bias. Alzheimer’s & Dementia: Diagnosis, Assessment, & Disease Monitoring, 8, e12250.
      22. Zill, EM, O’Donnell, A, Salinas, J, Aparicio, HJ, Gonzales, M.M, Jacob, M, Beiser, A, Seshadri, S. (2021). Herpes labialis, Chlamydophila pneumoniae, Helicobacter pylori and cytomegalovirus infections and risk of
        dementia: The Framingham Heart Study. Journal of Alzheimer’s Disease, 82, 593-605.
      23. Du, Y, Dennis, B, Liu, J, Meyer, K, Siddiqui, N, Lopez, K, White, C, Myneni, S, Gonzales, M.M, Wang, J. (2021). A conceptual model to improve care for individuals with Alzheimer’s disease and related dementias and their caregivers: Qualitative findings in an online caregiver forum. Journal of Alzheimer’s Disease, 81, 1673-1684.
      24. Gonzales, M.M, Short, M, Satizabal, C, O'Bryant, S, Tracy, R, Zare, H, Seshadri, S. (2021). Biomarkers for dementia in Hispanic and non-Hispanic white adults. Alzheimer's & Dementia: Translational Research & Clinical Intervention, 7, e12164.
      25. Gonzales, M.M., Wang, C.P., Quiben, M., MacCarthy, M., Seshadri, S., Jacob, M., & Hazuda, H. (2020). Joint trajectories of cognition and gait speed in Mexican Americans and European American older adults: The San Antonio Longitudinal Study of Aging.  International Journal of Geriatric Psychiatry, 35, 897-906.
      26. Morin, R., Gonzales, M.M., Bickford, D., Insel, P.S., Mackin, R.S. (2019). Impaired financial capacity in late-life depression: Revisiting associations with cognitive functioning. Journal of the International Neuropsychological Society, 25, 1088-1093. 
      27. Gonzales, M.M., Durazo-Arvizu, R.A., Sachdeva, S., Unterman, T.G., O'Brien, M.J., Gallo, L.C., Talavera, G.A., Kaplan, R.C., Cai, J., Schneiderman, N. Giacinto, R.A. & Lamar, M. (2019). Associations of insulin resistance with cognition in individuals without diagnosed diabetes: Results from the Hispanic Community Health Study/Study of Latinos. Diabetes Research and Clinical Practice, 150, 38-47.
      28. Gonzales, M.M., Insel, P.S., Nelson, C., Tosun, D., Scholl, M., Mattsson, N., Sacuiu, S., Bickford, D., Weiner, M.W., Mackin, R.S., & the Alzheimer’s Disease Neuroimaging Initiative (2018). Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment. International Journal of Geriatric Psychiatry, 33, 1305-1311. 
  • Clinical

    Provider profile

    Board Certifications

    • 2019 - Clinical Neuropsychology American Board of Professional Psychology
map image

UT Health San Antonio

7703 Floyd Curl Drive
San Antonio, TX 78229

210-567-7000

We make lives better ©

We're a part of UT Health San Antonio, provider of comprehensive health,  dental, &  cancer care,  advanced academics,  and  life-saving research.

Web Privacy | Links from websites affiliated with The University of Texas Health Science Center at San Antonio's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.